Avanza Fonder AB purchased a new stake in The Clorox Company (NYSE:CLX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 13,825 shares of the company’s stock, valued at approximately $2,245,000.
Several other institutional investors have also recently made changes to their positions in the stock. Mizuho Securities USA LLC increased its position in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after buying an additional 4,490,421 shares in the last quarter. Ilex Capital Partners UK LLP grew its stake in Clorox by 512.7% in the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after acquiring an additional 453,624 shares during the period. International Assets Investment Management LLC increased its holdings in shares of Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after acquiring an additional 435,971 shares in the last quarter. Boston Trust Walden Corp raised its position in shares of Clorox by 5,442.5% during the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock worth $44,622,000 after purchasing an additional 268,966 shares during the period. Finally, Assenagon Asset Management S.A. lifted its holdings in shares of Clorox by 302.0% in the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock worth $57,390,000 after purchasing an additional 265,455 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.
Analysts Set New Price Targets
Several research analysts have weighed in on the stock. Barclays lowered their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and upped their target price for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. JPMorgan Chase & Co. lifted their price target on Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research note on Thursday. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and lifted their target price for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Four analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $156.54.
Clorox Stock Performance
NYSE CLX opened at $160.31 on Friday. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The company has a market capitalization of $19.84 billion, a PE ratio of 55.86, a price-to-earnings-growth ratio of 2.90 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a 50-day simple moving average of $164.25 and a 200 day simple moving average of $156.38.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the previous year, the firm posted $0.49 EPS. Clorox’s revenue was up 27.0% on a year-over-year basis. On average, research analysts predict that The Clorox Company will post 6.87 EPS for the current year.
Clorox Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is currently 170.04%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- How to Short a Stock in 5 Easy Steps
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- What is the Dow Jones Industrial Average (DJIA)?
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- What is a Death Cross in Stocks?
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.